Organoids are physiologically relevant models for toxicity and safety assessment. Compared with conventional 2D cultures, they better recapitulate tissue architecture, electrophysiology, and organ-specific responses, providing a more representative model for preclinical research.
Within New Approach Methodologies (NAMs), organoids enable human-relevant toxicity testing and safety assessment, helping reduce reliance on animal models and support more translational research.
ACROBiosystems offers validated organoid models and supporting culture kits to enable reproducible toxicity screening and translational safety assessment with human-relevant data.

HotSep 24, 2026
This article reviews the progression from animal models and hERG screening to 2D hiPSC-CMs and cardiac organoids,highlighting how increasingly complex models may help capture tissue-level responses and improve the translational value of preclinical cardiac safety evaluation.
Read moreReceive expert perspectives, research trends, and workflow guidance across emerging therapeutic fields.